To view video, and read the full article visit URL http://crweselect.com/28273/stock-alerts/dgx-mig-pld-sho-crweselectcom-s...
Quest Diagnostics Incorporated (NYSE: DGX)
DGX announced that the U.S. Food and Drug Administration (FDA) has granted a de novo classification petition to its STRATIFY JCV? Antibody ELISA testing service. STRATIFY JCV is the first blood test to be FDA market authorized for the qualitative detection of antibodies to the polyomavirus JC virus (JCV) for stratifying risk for progressive multifocal leukoencephalopathy (PML), an infrequent but serious brain infection, in patients with multiple sclerosis (MS) receiving TYSABRI® (natalizumab), a highly effective therapy for relapsing forms of MS.
"The test has demonstrated its value as a tool that enhances PML risk assessment, and marks a significant step forward in the personalization of clinical management of MS patients who may benefit from natalizumab," stated Kathy P. Ordonez, senior vice president, discovery and development, Quest Diagnostics.
Quest Diagnostics reported last year that for the third quarter ended September 30, 2011 their revenues increased 2.2% to $1.9 billion for the third quarter. Quest Diagnostics recently announced that it will report fourth quarter and full year 2011 results and provide financial guidance for 2012 on Tuesday, January 24, 2012 before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
DGX is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
For more information about DGX please visit http://www.questdiagnostics.com
Meadowbrook Insurance Group, Inc. (NYSE: MIG) will be hosting a conference call on Wednesday, February 15, 2012 , at 9:00 a.m. EST to discuss fourth quarter and year end 2011 financial results. The fourth quarter 2011 financial results will be announced after the market closes on Tuesday, February 14, 2012 .
Meadowbrook Insurance Group, Inc., through its subsidiaries, operates as a specialty commercial insurance underwriter and insurance administration services company in the United States.
ProLogis, Inc. (NYSE: PLD) will host its Fourth Quarter and Year End 2011 Financial Results Webcast and Conference Call with senior management to discuss quarterly and full year results, current market conditions and future outlook on Wednesday, February 8, 2012 at 12:00 PM Eastern Time / 9:00 AM Pacific Time.
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe.
Sunstone Hotel Investors, Inc. (NYSE: SHO) announced that it will report financial results for the fourth quarter and full year 2011 on Tuesday, February 21, 2012 after the market closes. Management will hold its quarterly conference call on Wednesday, February 22, 2012 at 12:00 p.m. EST (9:00 a.m. PST). A live webcast of the call will be available via the Investor Relations section of the Sunstone Hotel Investors website at www.sunstonehotels.com. A replay of the webcast will also be archived on the website. Alternatively, investors may dial 1-877-941-9205 (for domestic callers) or 1-480-629-9645 (for international callers) to listen to the live call.
Sunstone Hotel Investors, Inc. operates as a real estate investment trust. The firm engages in the acquisition, ownership, asset management, renovation, and sale of luxury, upper upscale, and upscale full-service hotels in the United States. Its portfolio also includes mid-scale hotels.
To read the full article visit URL http://crweselect.com/28273/stock-alerts/dgx-mig-pld-sho-crweselectcom-s...
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.